MoonLake Immunotherapeutics
MLTX
#5894
Rank
A$1.57 B
Marketcap
A$22.22
Share price
5.12%
Change (1 day)
-72.44%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -A$0.33 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.2 Billion a decrease over its 2023 earnings that were of -A$81.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.33 Billion66.43%
2024 -A$0.2 Billion142.55%
2023 -A$81.34 Million-16.81%
2022 -A$97.77 Million